Recombinant factor VIIa: a general hemostatic agent? Not yet

被引：12

作者：

Levi, M

机构：

[1] Univ Amsterdam, Acad Med Ctr, Dept Internal Med, NL-1105 AZ Amsterdam, Netherlands

[2] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands

来源：

JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2004年 / 2卷 / 10期

关键词：

D O I：

10.1111/j.1538-7836.2004.00912.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：1695 / 1697

页数：3

共 21 条

[1]

Bauer KA, 1996, HAEMOSTASIS, V26, P155

[2] Recombinant activated factor VII for the treatment of life-threatening haemorrhage [J].

Eikelboom, JW ;

Bird, R ;

Blythe, D ;

Coyle, L ;

Gan, E ;

Harvey, M ;

Isbister, J ;

Leahy, M ;

McIlroy, D ;

Rahimpanah, F ;

Ramanthan, S ;

Strasser, S ;

Ward, C ;

Watts, A ;

Towler, S ;

Yi, QL .

BLOOD COAGULATION & FIBRINOLYSIS, 2003, 14 (08) :713-717

[3] Effect of recombinant activated factor VII on perioperative blood loss in patients undergoing retropubic prostatectomy:: a double-blind placebo-controlled andomised trial [J].

Friederich, PW ;

Herny, CP ;

Messelink, EJ ;

Geerdink, MG ;

Keller, T ;

Kurth, KH ;

Büller, HR ;

Levi, M .

LANCET, 2003, 361 (9353) :201-205

[4] USE OF HUMAN FACTOR-VIIA IN THE TREATMENT OF 2 HEMOPHILIA A PATIENTS WITH HIGH-TITER INHIBITORS [J].

HEDNER, U ;

KISIEL, W .

JOURNAL OF CLINICAL INVESTIGATION, 1983, 71 (06) :1836-1841

[5]

Hedner U, 1998, BLOOD COAGUL FIBRIN, V9, pS147

[6] An effective treatment of severe intractable bleeding after valve repair by one single dose of activated recombinant factor VII [J].

Hendriks, HGD ;

van der Maaten, JMAA ;

de Wolf, J ;

Waterbolk, TW ;

Slooff, MJH ;

van der Meer, J .

ANESTHESIA AND ANALGESIA, 2001, 93 (02) :287-289

[7] The sixth (2000) ACCP guidelines for antithrombotic therapy for prevention and treatment of thrombosis [J].

Hirsh, J ;

Dalen, JE ;

Guyatt, G .

CHEST, 2001, 119 (01) :1S-2S

[8] Efficacy and safety of recombinant factor VIIa in the prophylaxis of bleeding in various surgical procedures in hemophilic patients with factor VIII and factor IX inhibitors [J].

Ingerslev, J .

SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2000, 26 (04) :425-432

[9] Treatment of traumatic bleeding with recombinant factor VIIa [J].

Kenet, G ;

Walden, R ;

Eldad, A ;

Martinowitz, U .

LANCET, 1999, 354 (9193) :1879-1879

[10] Incorporating manufacturing tolerances in near-optimal design of composite structures [J].

Kristinsdottir, BP ;

Zabinsky, ZB ;

Tuttle, ME ;

Csendes, T .

ENGINEERING OPTIMIZATION, 1996, 26 (01) :1-23

← 1 2 3 →